21 Jun 2016 17:30
For immediate release | 21 June 2016 |
Futura Medical PLC
("Futura" or the "Company")
Result of AGM
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, confirms that all resolutions were duly passed at its Annual General Meeting held today.
For further information:
Futura Medical plc | + 44 (0) 1483 685 670 |
James Barder, Chief Executive | |
Mail to: James.Barder@futuramedical.com | www.futuramedical.com |
N+1 Singer (Nominated Advisor & Broker) | +44 (0) 20 7496 3000 |
Aubrey Powell / Liz Yong www.alliancepharma.co.uk | |
Corporate Finance | |
Buchanan | + 44 (0) 20 7466 5000 |
Mark Court / Sophie Cowles / Stephanie Watson |
Notes to editors:
About Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange. www.futuramedical.com
Futura Medical (FUM)